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Curli are functional amyloid fibers that constitute the major protein 
component of the extracellular matrix in pellicle biofilms formed by 
Bacteroidetes and Proteobacteria (predominantly - and -)1-3. They provide a 
fitness advantage in pathogenic strains and induce a strong pro-inflammatory 
response during bacteremia1,4,5. Curli formation requires a dedicated protein 
secretion machinery comprised of the outer membrane lipoprotein CsgG and two 
soluble accessory proteins, CsgE and CsgF 6,7. Here we report the X-ray structure 
of E. coli CsgG in a non-lipidated, soluble form as well as in its native membrane-
extracted conformation. CsgG forms an oligomeric transport complex composed 
of nine anticodon binding domain (ABD)-like units that give rise to a 36-stranded 
-barrel that traverses the bilayer and is connected to a cage-like vestibule in the 
periplasm. The transmembrane and periplasmic domains are separated by a 0.9 
nm channel constriction composed of three stacked concentric phenylalanine-, 
asparagine- and tyrosine-rings that may guide the extended polypeptide substrate 
through the secretion pore. The specificity factor CsgE forms a nonameric 
adaptor that binds and closes off the periplasmic face of the secretion channel, 
creating a 24.000 Å3 pre-constriction chamber. Our structural, functional and 
electrophysiological analyses imply that CsgG is an ungated, non-selective protein 
secretion channel that likely employs a diffusion-based, entropy-driven transport 
mechanism.  
 
Curli are bacterial surface appendages that have structural and physical 
characteristics of amyloid fibrils, best known from human degenerative diseases7-9. 
However, the role of bacterial amyloids such as curli are to facilitate biofilm formation 
4,10. Unlike pathogenic amyloids, which are the product of protein misfolding, curli 
formation is coordinated by proteins encoded in two dedicated operons, csgBAC (curli 
specific genes BAC) and csgDEFG in Escherichia coli (Extended Data Fig. 1)6,7. Upon 
secretion, CsgB nucleates CsgA subunits into curli fibers 7,11,12. Secretion and 
extracellular deposition of CsgA and CsgB is dependent on two soluble accessory 
factors, CsgE and CsgF, respectively, as well as CsgG, a 262-residue lipoprotein 
located in the outer membrane (OM)13-16. Due to the lack of hydrolyzable energy 
sources or ion gradients at the outer membrane, CsgG falls into a specialized class of 
protein translocators that must operate through an alternatively energized transport 
mechanism. In the absence of a structural model, the dynamic workings of how CsgG 
promotes secretion and assembly of highly stable amyloid-like fibers in a regulated 
fashion across a biological membrane has thus far remained enigmatic.  
Prior to insertion into the OM, lipoproteins are piloted across the periplasm via 
the lipoprotein localization (Lol) pathway17. We observed that non-lipidated CsgG 
(CsgGC1S) could be isolated as a soluble periplasmic intermediate, analogous to the 
pre-pore forms observed in pore-forming proteins and toxins18. CsgGC1S was found 
predominantly as monomers, in addition to a minor fraction of discrete oligomeric 
complexes (Extended Data Fig. 2)19. The soluble CsgGC1S oligomers were crystallized 
and their structure was determined to 2.8 Å, revealing a hexadecameric particle with 
8-fold dihedral symmetry (D8), consisting of two ring-shaped octameric complexes 
(C8) that are joined in a tail-to-tail interaction (Extended Data Fig. 2 and Fig. 1). The 
CsgGC1S protomer shows an anticodon binding domain (ABD)-like fold that is 
extended with two -helices at the N- and C-terminus (N and C, resp.; Fig. 1 and 
Extended Data Fig. 3a-c). Additional CsgG-specific elements are an extended loop 
linking 1 and 1, two insertions in the loops connecting 3-4 and 5-3 and an 
extended 2 helix that is implicated in CsgG oligomerization by packing between 
adjacent monomers (Fig. 1b). Further inter protomer contacts are formed between the 
back of the 3-5 sheet and the extended 1-1 loop (Extended Data Fig. 3d, e).  
In the CsgGC1S structure, residues 1-17, which would link 1 to the N-terminal 
lipid anchor, are disordered and no obvious transmembrane (TM) domain can be 
discerned (Fig. 1). Attenuated Total Reflection Fourier Transform Infrared 
spectroscopy (ATR-FTIR) of CsgGC1S and native, membrane-extracted CsgG reveals 
the latter exhibits a higher absorption in the -sheet region (1625-1630 cm-1) and a 
concomitant reduction in the random coil and -helical regions (1645-1650 cm-1 and 
1656 cm-1, resp., Fig. 2a), suggesting membrane associated CsgG contains a -barrel 
domain. Candidate sequence stretches for -strand formation are found in the poorly 
ordered, extended loops connecting 3-4 (residues 134-154) and 5-3 (residues 
184-204) and deletion of these resulted in the loss of curli formation (Fig. 2b). The 
crystal structure of detergent extracted CsgG confirms a conformational rearrangement 
of both regions into two adjacent -hairpins, extending the -sheet formed by 3-4 
(TM1) and 5-3 (TM2), respectively (Fig. 2c). Their juxtaposition in the CsgG 
oligomer gives rise to a composite 36-stranded -barrel (Fig. 2d). Remarkably, 
whereas the crystallized CsgCC1S oligomers show a D8 symmetry, the CsgG structure 
shows D9 symmetry, with CsgG protomers retaining equivalent interprotomer 
contacts, except for a 5 rotation relative to the central axis and a 4 Å translation along 
the radial axes  (Extended Data Fig. 2). This observation is reconciled in the in 
solution oligomeric states revealed by single-particle EM, which exclusively finds C9 
and D9 symmetries for membrane-extracted CsgG (Extended Data Figs 2). The 
predominant presence of monomers in the non-lipidated sample and the symmetry 
mismatch with the membrane-bound protein argue that before membrane insertion, 
CsgG is targeted to the outer membrane in a monomeric, LolA-bound form and that 
C8 and D8 particles are an artifact of highly concentrated solutions of CsgGC1S. 
Furthermore, we show the C9 nonamer rather than the D9 complex forms the 
physiologically relevant particle since in isolated E. coli outer membranes, cysteine 
substitutions in residues enclosed by the observed tail-to-tail dimerization are 
accessible to maleimide-polyethylene glycol (PEG – 5 kDa) labeling (Extended Data 
Fig. 4).  
Thus, CsgG forms a nonameric transport complex of 120 Å width and 85 Å 
height. The complex traverses the outer membrane through a 36-stranded -barrel of 
40 Å inner diameter (Fig. 2e). The N-terminal lipid anchor is separated from the core 
domain by an 18-residue linker that wraps over the adjacent protomer (Extended Data 
Fig. 3d). The diacylglycerol- and amide-linked acyl chain on the N-terminal Cys are 
not resolved in the electron density maps, but based on the location of Leu 2 the lipid 
anchor is expected to flank the outer wall of the -barrel. On the periplasmic side, the 
transporter forms a large solvent–accessible cavity of 35 Å inner diameter and 40 Å 
height that opens to the periplasm in a 50 Å mouth formed by helix 2 (Fig. 2e). At its 
apex, this periplasmic vestibule is separated from the TM channel by a conserved 12-
residue loop connecting 1-1 (C-loop, “CL”; Fig. 2e, Fig. 3a, b), which constricts the 
secretion conduit to a solvent-excluded diameter of 9.0 Å (Fig. 3a, c). These pore 
dimensions would be compatible with the residence of one to two (e.g. a looped 
structure) extended polypeptide segments, with 5 residues spanning the height of the 
constriction (Extended Data Fig. 5). The luminal lining of the constriction is composed 
of three stacked concentric rings formed by the side chains of residues Y51, N55 and 
F56 (Fig. 3a, b). Strikingly, in the anthrax PA63 toxin, a topologically equivalent 
concentric Phe ring (referred to as -clamp) lines the entry of the translocation channel 
and catalyzes polypeptide capture and passage 20-22. Multiple sequence alignment of 
CsgG-like translocators shows the absolute conservation of the F56 and the 
conservative variation of N55 to Ser or Thr (Extended Data Fig. 6). Mutation of F56 
or N55 to Ala leads to a near loss in curli production (Fig. 3d), whereas a N55S 
substitution retains wild-type secretion levels, together alluding to the requirement of 
the stacked configuration of a -clamp followed by a H-bond donor/acceptor in the 
CsgG constriction (Extended Data Fig. 6, Fig. 3b).  
Single-channel current recordings of CsgG reconstituted in planar phospholipid 
bilayers led to a steady current of 43 ± 5 pA (n = 32), - 45 ± 4 pA (n = 13) using 
standard electrolyte conditions and a potential of + 50 mV or – 50 mV, respectively 
(Fig. 3e, f, Extended Data Fig. 7). The observed current was in good agreement with 
the predicted value of 46 pA calculated based on a simple three-segment pore model 
and the dimensions of the central constriction seen in the X-ray structure (Fig. 3c). A 
second, low conductance conformation can also be observed under negative electrical 
field potential (-25 ± 4 pA; Extended Data Fig. 7). It is unclear, however, whether this 
species is present under physiological conditions.  
Our structural data and single-channel recordings infer CsgG forms an ungated 
peptide diffusion channel. In PA63, a model peptide diffusion channel, polypeptide 
passage depends on a pH-driven Brownian ratchet that rectifies the diffusive steps in 
the translocation channel20-22. Such proton gradients, however, are not present at the 
outer membrane, requiring an alternative driving force. Whereas at elevated 
concentrations CsgG facilitates non-selective diffusive leakage of periplasmic 
polypeptides, secretion is specific for CsgA under native conditions and requires the 
periplasmic factor CsgE16,23. In presence of an excess CsgE, purified CsgG forms a 
slower migrating species on native PAGE (Fig. 4a). SDS-PAGE analysis shows this 
new species consists of a CsgG:CsgE complex that is present in a 1:1 stoichiometry 
(Fig. 4b). CryoEM visualization of CsgG:CsgE isolated by pull-down affinity 
purification reveals a 9-fold symmetrical particle corresponding to the CsgG nonamer 
and an additional capping density at the entrance to the periplasmic vestibule, similar 
in size and shape to a C9 CsgE oligomer also observed by single-particle EM and size 
exclusion chromatography (Fig. 4c-e, Extended Data Fig. 8). The location of the 
observed CsgG:CsgE contact interface is corroborated by blocking point mutations in 
CsgG helix 2 (Extended Data Fig. 8). In agreement with a capping function, single 
channel recordings show that CsgE binding to the translocator leads to the specific 
silencing of its ion conductance (Fig. 4f, Extended Data Fig. 7). This CsgE capping of 
the channel appears an all or none response in function of CsgE nomamer binding. At 
saturation, CsgE binding induces full blockage of the channel, whilst around 10 nM, 
an equilibrium between CsgE binding and dissociation events results in an 
intermittently blocked or fully open translocator. At 1 nM or below, transient (<1 
millisecond) partial blockage events may stem from short-lived encounters with 
monomeric CsgE. 
 Thus, CsgG and CsgE appear to form an encaging complex enclosing a central 
cavity of ~24.000 Å3, reminiscent in appearance to the substrate binding cavity and 
encapsulating lid structure seen in the GroEL chaperonin and GroES cochaperonin24. 
The CsgG:CsgE enclosure would be compatible with the full or partial entrapment of 
the 129-residue CsgA. Interestingly, the caging of a translocation substrate has 
recently been observed in ABC toxins25. Spatial confinement of an unfolded 
polypeptide leads to a decrease in its conformational space, creating an entropic 
potential that has been shown to favor polypeptide folding in case of chaperonins24,26. 
Similarly, we speculate that in curli transport the local high concentration and 
conformational confinement of curli subunints in the CsgG vestibule would generate 
an entropic free energy gradient over the translocation channel (Fig. 4g). Upon capture 
into the constriction, the polypeptide chain is then expected to progressively move 
outwards by Brownian diffusion, rectified by the entropic potential generated from the 
CsgE-mediated confinement and/or substrate-trapping near the secretion channel. In 
case of a full confinement in the pre-constriction cavity, escape of an unfolded 129-
residue polypeptide to the bulk solvent would correspond to an entropic free energy 
release of up to ~80 kcal/mole 27.  The initial entropic cost of substrate docking and 
confinement are likely to be at least partially compensated by binding energy released 
during assembly of the CsgG:CsgE:CsgA complex and an already lowered CsgA 
entropy in the periplasm. On theoretical grounds, three potential routes of CsgA 
recruitment to the secretion complex can be envisaged (Extended Data Fig. 9).  
Curli-induced biofilms form a fitness and virulence factor in pathogenic 
Enterobacteriaceae 4,5. Their unique secretion and assembly properties are also rapidly 
gaining interest for (bio)technological application23,28,29. Our structural 
characterization and biochemical study of two key secretion components provide a 
tentative model of an iterative mechanism for the membrane translocation of unfolded 
protein substrates in absence of a hydrolysable energy source, a membrane potential or 
ion gradient (Fig. 4e, Extended Data Fig. 9). The full validation and deconstruction of 
the contributing factors in the proposed secretion model will require the in vitro 
reconstitution of the translocator in order to accurately follow transport kinetics at the 
single molecule level.  
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Figure 1. X-ray structure of CsgGC1S in pre-pore conformation. (a) Ribbon 
diagram of the CsgGC1S monomer colored as blue to red rainbow from the N- to C-
terminus. Secondary structure elements are labeled according the ABD-like fold, with 
the additional N- and C-terminal -helices, and extended loop connecting 1and 1 
labeled N,C and CL (C-Loop), respectively. (b) Side view of the CsgGC1S C8 
octamer with subunits differentiated by color and one subunit oriented and colored as 
in (a).  
 
Figure 2. Structure of CsgG in its channel conformation. (a) Amide I region (1700 
– 1600 cm-1) of ATR-FTIR spectra of CsgGC1S (blue) and membrane-extracted CsgG 
(red) (b) TM1 and TM2 sequence (bilayer facing residues in blue) and Congo Red 
binding of E. coli BW25141csgG complemented with wild type csgG (WT), empty 
vector or csgG lacking underscored fragments of TM1 or TM2. (c) Overlay of CsgG 
monomer in pre-pore (light blue) and channel conformation (tan). (d, e) Side and 
cross-sectional view of CsgG nonamers in ribbon and surface representation, and 
Helix 2, the core domain and TM hairpins shown in blue, light blue and tan, 
respectively. A single protomer is colored according Fig. 1a. Magenta spheres show 
position of Leu 2. (OM: outer membrane, CL: C-loop). 
 
Figure 3. CsgG channel constriction. (a) Cross-section of CsgG channel constriction 
and its solvent-excluded diameters. (b) The constriction is composed of 3 stacked 
concentric side chain layers: Y51, N55 and F56, preceded by F48 from the periplasmic 
side. (c) Congo Red binding of E. coli BW25141csgG complemented with csgG 
(WT), empty vector or csgG carrying indicated constrictions mutants. (c, d) 
Representative single-channel current recordings and conductance histogram (d) of 
CsgG reconstituted in planar phopsholipid bilayers (PPB) and measured under an 
electrical field of + (n=32) or -50 mV (n=13).  
 
Figure 4. Model of CsgG transport mechanism. (a) Native PAGE of CsgE (E), 
CsgG (G) and CsgG supplemented with an excess CsgE (E+G) shows the formation of 
a CsgG:CsgE complex (E:G*). (b) SDS-PAGE of CsgE (E), CsgG  (G) and the E:G* 
complex recovered from native PAGE. (MW: Molecular Weight markers in kDa). (c) 
Selected class averages of CsgG:CsgE particles. From left to right: top and side view 
visualized by cryo-EM; and comparison of negatively stained side views with CsgG 
nonamers. (d) CryoEM averages of top and tilted side viewed CsgE particles. 
Rotational autocorrelation shows 9-fold symmetry. (e) 3D reconstruction of 
CsgG:CsgE (24 Å resolution, 1221 single particles) shows a nonameric particle 
comprised of CsgG (blue) and an additional density assigned as a CsgE nonamer 
(orange). (f) Single channel current recordings of PPB-reconstituted CsgG at + or -50 
mV and supplemented with incremental concentrations of CsgE. (horizontal scale bars 
lie at 0 pA) (g) Tentative model for CsgG-mediated protein secretion. CsgG and CsgE 
are proposed to form a secretion complex that entraps CsgA (discussed in Extended 
Data Figure 9), generating an entropic potential over the channel. Upon capture of 
CsgA in the channel constriction, a S-rectified Brownian diffusion facilitates the 




Cloning and strains 
Expression constructs for production of outer membrane localized C-terminally 
StrepII-tagged CsgG (pPG1) and periplasmic C-terminally StrepII-tagged CsgGC1S 
(pPG2) have been described in Goyal et al. 2013 19. For selenomethionine labeling, 
StrepII-tagged CsgGC1S was expressed in the cytoplasm because of increased yields. 
Therefore, pPG2 was altered to remove the N-terminal signal peptide using inverse 
PCR with primers forward: 5'- TCT TTA AC CGC CCC GCC TAA AG -3' and 
reverse: 5'- CAT TTT TTG CCC TCG TTA TC -3' (pPG3). For phenotypic assays, a 
csgG deletion mutant of E. coli BW25141 (E. coli NVG2) was constructed by the 
method described by Datsenko and Wanner 30 (with primers 5’- AAT AAC TCA ACC 
GAT TTT TAA GCC CCA GCT TCA TAA GGA AAA TAA TCG TGT AGG CTG 
GAG CTG CTT C-3’ and 5’- CGC TTA AAC AGT AAA ATG CCG GAT GAT 
AAT TCC GGC TTT TTT ATC TGC ATA TGA ATA TCC TCC TTA G-3’). The 
various CsgG substitution mutants used for Cys accessibility assays and for 
phenotypic probing of the channel constriction were constructed by site-directed 
mutagenesis (QuikChange protocol, Stratagene) starting from pMC2, a pTRC99a 
vector containing csgG under control of the trc promotor 14. 
Protein expression and purification 
CsgG and CsgGC1S were expressed and purified as described 
19. Briefly, CsgG was 
recombinantly produced in E. coli BL 21 (DE3) transformed with pPG1 and extracted 
from isolated outer membranes using 1 % n-dodecyl--D-maltoside (DDM) in buffer 
A: 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM ethylene diamine tetraacetic acid 
(EDTA), 1 mM dithiothreitol (DTT). Strep-II tagged CsgG was loaded onto a 5 mL 
Strep-Tactin sepharose column (Iba GmbH) and detergent-exchanged by washing with 
20 column volumes buffer A supplemented with 0.5% tetraethylene glycol monooctyl 
ether (C8E4, Affymetrix) and 4 mM lauryldimethylamine-N-oxide (LDAO, 
Affymetrix). The protein was eluted by addition of 2.5 mM D-desthiobiotin and 
concentrated to 5 mg mL-1 for crystallization experiments. For selenomethionine 
labeling, CsgGC1S was produced in the Met auxotrophic strain B834 (DE3) 
transformed with pPG3 and grown on M9 minimal medium supplemented with 40 mg 
L-1 L-selenomethionine. Cell pellets were resuspended in 50 mM Tris-HCl pH 8.0, 
150 mM NaCl, 1 mM EDTA, 5 mM DTT, supplemented with cOmplete Protease 
Inhibitor Cocktail (Roche) and disrupted by passage through a TS series cell disruptor 
(Constant Systems Ltd) operated at 20 kPsi. Labeled CsgGC1S was purified as 
described 19. 5 mM dithiothreitol (DTT) was added throughout the purification 
procedure to avoid selenomethionine oxidation. 
CsgE was produced in E. coli NEBC2566 cells harboring pNH27 16. Cell lysates in 25 
mM Tris-HCl pH 8.0, 150 mM NaCl, 25 mM Imidazol, 5 % (v/v) glycerol were 
loaded on a HisTrapTM FF (GE Healthcare). CsgE-his was eluted with a linear gradient 
to 500 mM Imidazol in 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 (v/v) % glycerol 
buffer. Fractions containing CsgE were supplemented with 250 mM (NH4)2SO4 and 
applied on a 5 ml HiTrapTM Phenyl HP column (GE Healthcare) equilibrated with 20 
mM Tris-HCl pH 8.0, 100 mM NaCl, 250 mM (NH4)2SO4, 5 (v/v) % glycerol. A 
linear gradient to 20 mM Tris-HCl pH 8.0, 10 mM NaCl, 5 (v/v) % glycerol was 
applied for elution. CsgE containing fractions were loaded on Superose 6 PREP Grade 
10/600 (GE Healthcare) column equilibrated in 20 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 5 (v/v) % glycerol. 
 
 
In solution oligomeric state assessment 
Approximately 0.5 mg each of detergent-solubilized CsgG (0.5% C8E4, 4 mM 
LDAO) and CsgGC1S were applied to a Superdex 200 10/300 GL analytical gel 
filtration column (GE Healthcare) equilibrated with 25 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 1 mM DTT, 4 mM LDAO, and 0.5% C8E4 (CsgG) or 25 mM Tris-HCl pH 8.0, 
200 mM NaCl (CsgGC1S), and run at 0.7 mL min
-1. The column elution volumes were 
calibrated using bovine thyroglobulin, bovine -globulin, chicken ovalbumin, horse 
myoglobulin and vitamin B12 (Bio-Rad) (Extended Data Fig. 2). Membrane-
extraceted CsgG, 20 μg of the detergent-solubilized protein was also run on a 3-10% 
blue native PAGE using the procedure described by Swamy et al. 31 (Extended Data 
Fig. 2). NativeMark (Life Technologies) unstained protein standard (7 μL) was used 
for molecular weight estimation. 
 
Crystallization, data collection and structure determination 
Selenomethionine labeled CsgGC1S was concentrated to 3.8 mg mL
-1 and crystallized 
by sitting drop vapor diffusion against a solution containing 100 mM sodium acetate 
pH 4.2, 8% PEG 4000 and 100 mM sodium malonate pH 7.0. Crystals were incubated 
in crystallization buffer supplemented with 15 % glycerol and flash-frozen in liquid 
nitrogen. Detergent-solubilized CsgG was concentrated to 5 mg mL-1 and crystallized 
by hanging drop vapor diffusion against a solution containing 100 mM Tris-HCl pH 
8.0, 8% PEG 4000, 100 mM NaCl and 500 mM MgCl2. Crystals were flash-frozen in 
liquid nitrogen and cryoprotected by the detergent present in the crystallization 
solution. For optimization of crystal conditions and screening for crystals with good 
diffraction quality, crystals were analyzed on beamlines Proxima-1, Proxima-2a 
(Soleil, France), PX-I (Swiss Light Source, Swiss), I02, I03, I04, I24 (Diamond Light 
Source, UK) and ID14eh2, ID23eh1, ID23eh2 (ESRF, France). Final diffraction data 
used for structure determination of CsgGC1S and CsgG were collected at beamlines I04 
and I03, respectively (Diamond Light Source, UK) (see Extended Data Table 1 for 
data collection and refinement statistics). Diffraction data for CsgGC1S were processed 
using the Xia2 and the XDS package32,33. Crystals of CsgGC1S belonged to space group 
P1 with unit cell dimensions of a = 101.3 Å, b = 103.6 Å, c = 141.7 Å, α = 111.3°, β = 
90.5°, γ = 118.2°, containing 16 protein copies in the asymmetric unit (AU). For 
structure determination and refinement, date collected at 0.9795 Å wavelength were 
truncated at 2.8 Å based on an I/I cutoff of 2 in the highest resolution shell. The 
structure was solved using experimental phases calculated from a Single Anomalous 
Dispersion (SAD) experiment. 92 selenium sites were located in the AU using ShelxC 
and ShelxD34, and refined and used for phase calculation with Sharp35 (phasing power: 
0.79, figure of merit (FOM): 0.25). Experimental phases were density modified and 
non-crystallographic symmetry (NCS) -averaged using Parrot36 (Extended Data Fig. 
10; FOM: 0.85). An initial model was built with Buccaneer37 and refined by iterative 
rounds of maximum likelihood refinement with Phenix refine38 and manual inspection 
and model (re)building in Coot39. The final structure contains 28853 atoms in 3700 
residues belonging to 16 CsgGC1S chains (Extended Data Figs. 2), with a molprobity
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score of 1.34, and 98 % of the residues lying in favored regions of the Ramachandran 
plot (99.7 % in allowed regions). Electron density maps showed no unambiguous 
density corresponding to possible solvent molecules and no water molecules or ions 
were, therefore, built in. 16-fold NCS averaging was maintained throughout 
refinement, using strict and local NCS restraints in early and late stages of refinement, 
respectively.  
Diffraction data for CsgG were collected from a single crystal at 0.9763 Å wavelength 
and were indexed and scaled, using the XDS package32,33, in space group C2 with unit 
cell dimensions a = 161.7 Å, b = 372.3 Å, c = 161.8 Å and β = 92.9°, encompassing 18 
CsgG copies in the AU and a 72 % solvent content. Diffraction data for structure 
determination and refinement were elliptically truncated to resolution limits of 3.6 Å, 
3.7 Å and 3.8 Å along reciprocal cell directions a*, b* and c* and anisotropically 
scaled using the Diffraction Anisotropy Server41. Molecular replacement using the 
CsgGC1S monomer proved unsuccessful. Analysis of the self rotation function revealed 
D9 symmetry in the asymmetric unit (not shown). Based on the CsgGC1S structure, a 
nonameric search model was generated in the assumption that upon going from a C8 to 
C9 oligomer, the interprotomer arc at the particle circumference would stay 
approximately the same as the interprotomer angle changes form 45 to 40, giving a 
calculated increase in radius of approximately 4 Å. Using the calculated nonamer as 
search model, a molecular replacement solution containing to copies was found with 
Phaser42. Inspection of density-modified and NCS-averaged electron density maps 
(Parrot36; Extended Data Fig. 10) allowed manual building of the TM1 and TM2 and 
remodeling of adjacent residues in the protein core, as well as the building of residues 
2 to 18, which were missing from the CsgGC1S model and link the 1 helix to the N-
terminal lipid anchor. Refinement of the CsgG model was performed with Buster-
TNT43 and Refmac544 for initial and final refinement rounds, respectively. 18-fold 
local NCS restraints were applied throughout refinement and Refmac5 was run 
employing a jelly-body refinement with sigma 0.01 and H-bond restraints generated 
by Prosmart45. The final structure contains 34165 atoms in 4451 residues belonging to 
18 CsgG chains (Extended Data Fig. 2), with a molprobity score of 2.79 and 93.0 % of 
the residues lying in favored regions of the Ramachandran plot (99.3 % in allowed 
regions). No unambiguous electron density corresponding the N-terminal lipid anchor 
could be discerned.  
 
Congo Red assay 
For analysis of Congo Red binding, a bacterial overnight culture grown at 37°C in LB 
medium was diluted in Lysogeny Broth (LB) till an OD600nm of 0.5. Five l was 
spotted on LB agar plates supplemented with ampicillin (100 mg L-1), Congo Red (100 
mg l-1) and 0.1% (w/v) isopropyl β-D-1-thiogalactopyranoside (IPTG). Plates were 
incubated at room temperature for 48 hours to induce curli expression. The 
development of the colony morphology and dye binding was observed at 48 hours. 
 
Cysteine accessibility assays 
Cysteine mutants were generated in pMC2 using site directed mutagenesis and 
expressed in E. coli LSR12 7. Bacterial cultures grown overnight were spotted onto LB 
agar plates containing 1 mM IPTG and 100 mg L-1 ampicillin. Plates were incubated at 
room temperature and cells were scrapped after 48 hours, resuspended in 1 mL 
Phosphate Buffered Saline (PBS) and normalized using OD600nm. The cells were lysed 
by sonication and centrifuged for 20 sec at 3000 RCF at 4°C to remove unbroken cells 
from cell lysate and suspended membranes. Proteins in the supernatant were labeled 
using 15 mM methoxypolyethylene glycol-maleimide (MAL-PEG 5 kDa) for one hour 
at room temperature. The reaction was stopped using 100 mM DTT and centrifuged at 
40, 000 rpm in 50.4 Ti rotor for 20 min at 4°C to pellet total membranes. The pellet 
was washed with 1% sodium lauroyl sarcosinate to solubilize cytoplasmic membranes 
and again centrifuged. The resulting outer membranes were resuspended and 
solubilized using PBS containing 1% DDM. Metal affinity pull downs done using 
nickel beads were used for SDS-PAGE and anti his western blots. E. coli LSR12 cells 
with empty pMC2 vector were used as negative control. 
 
Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) 
spectroscopy 
ATR-FTIR measurements were performed on an Equinox 55 infrared 
spectrophotometer (Bruker), continuously purged with dried air, equipped with a 
liquid nitrogen-refrigerated Mercury Cadmium Telluride detector and a Golden Gate 
reflectance accessory (Specac). The internal reflection element was a diamond crystal 
(2 mm x 2 mm) and the beam incidence angle was of 45°. 1 µL of each purified 
protein sample was spread at the surface of the crystal and dried under a gaseous 
nitrogen flow to form a film. Each spectrum, recorded at a 2 cm-1 resolution, was an 
average of 128 accumulations for improved signal-to-noise ratio. All the spectra were 
treated with water vapor contribution subtraction, smoothed at a final resolution of 4 
cm−1 by apodization and normalized on the area of Amide I band (1700 – 1600 cm-1) 
in order to allow their comparison46. 
 
Negative stain EM and symmetry determination 
Negative stain EM was used to monitor in solution oligomerization states of CsgG, 
CsgGC1S and CsgE. CsgE, CsgGC1S  and amphipol-bound CsgG were adjusted to a 
concentration of 0.05 mg mL-1 and applied to glow-discharged carbon-coated copper 
grids (CF-400, Electron Microscopy Sciences). After 1 minute incubation, samples 
were blotted, then washed and stained in 2 % uranyl acetate. Images were collected on 
a Tecnai T12 BioTWIN LaB6 microscope operating at a voltage of 120 kV, at 
magnification of 49,000 and defocus between 800 - 2000 nm. CTF, phase flipping and 
particle selection was performed as described for cryo-EM. For membrane-extracted 
CsgG, octadecameric particles (1780 total) were analyzed separately from nonamers 
and top views. For purified CsgE a total of 2452 particles were analyzed. 3D models 
were obtained as described for the CsgG:CsgE cryo-EM analysis below and refined by 
several rounds of MRA, MSA and anchor set refinement. In all cases, after 
normalization and centering, images were classified using IMAGIC-4D as described 
in the cryo-EM section The best classes corresponding to characteristic views were 
selected for each set of particles. Symmetry determination of CsgG top views was 
performed using the best class averages with approximately 20 images per class. The 
rotational auto-correlation function was calculated using IMAGIC and plotted. 
 
CsgG:CsgE complex formation 
For CsgG:CsgE complex formation, the solubilizing detergents in purified CsgG were 
exchanged for Amphipols A8-35 (Anatrace) by adding 120 L CsgG (24 mG mL-1 
protein in 0.5% C8E4, 4 mM LDAO, 25 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM 
DTT) to 300 L detergent-destabilized liposomes (1mg mL-1 DMPC and 0.4% 
LDAO) and incubating for 5 minutes on ice before the addition of 90 L of A8-35 
amphipols at 100 mg mL-1stock. After additional 15 min incubation on ice, the sample 
was loaded on a Superose 6 10/300 GL (GE Healthcare) column and gel filtration was 
performed in 200 mM NaCl, 2.5% xylitol, 25 mM Tris pH 8, and 0.2 mM DTT. Equal 
volumes of purified monomeric CsgE in 200mM NaCl, 2.5% xylitol, 25 mM Tris-HCl 
pH 8, and 0.2mM DTT was added to the amphipol-solubilized CsgG at final protein 
concentrations of 15 and 5 M for CsgE and CsgG, respectively, and the sample was 
run at 125 V at 18 C on a 4.5 % native PAGE in 0.5x TBE (Tris/Borate/EDTA) 
buffer. For the second, denaturing dimension, the band corresponding to the 
CsgG:CsgE complex was cut out of unstained lanes ran in parallel on the same gel, 
boiled for 5 minutes in Laemmli buffer (60 mM Tris-HCl pH 6.8, 2% SDS, 10% 
glycerol, 5% β-mercaptoethanol, 0.01% bromophenol blue) and run in a 4-20% SDS-
PAGE. Purified CsgE and CsgG were run alongside the complex as control samples. 
Gels were stained with InstantBlueTM coomassie for visual inspection or SYPRO 
orange for stoichiometry assessment of the CsgG:CsgE complex by fluorescence 
detection (Typhoon FLA 9000) of the CsgE and CsgG bands on SDS-PAGE, yielding 
a CsgG/CsgE ratio of 0.97. 
 
CsgG:E CryoEM 
Cryo electron microscopy was used to determine the in solution structure of the C9 
CsgG:CsgE complex. CsgG:CsgE complex prepared as described above was bound 
and eluted from a HisTrapTM FF (GE Healthcare) to remove unbound CsgG and upon 
elution immediately applied on a Quantifoil R2/2 carbon coated grids (Quantifoil 
Micro Tools GmbH) that had been glow discharged at 20mA for 30 seconds. Samples 
were plunge-frozen in liquid nitrogen using an automated system (Leica) and 
visualized on a FEI F20 microscope operating at a voltage of 200 kV, a nominal 
magnification of 50,000 under low dose conditions and a defocus range of 1.4-3 μm. 
Image frames were recorded on a Falcon II detector. The pixel size at the specimen 
level was 1.9 Å per pixel. The CTF (contrast transfer function) parameters were 
assessed using CTFFIND3 47, and the phase flipping was done in SPIDER 48. Particles 
were automatically selected from CTF-corrected micrographs using BOXER (EMAN2 
49).  Images with an astigmatism of more than 10% were discarded. 4881 particle 
images were selected from 145 frames and windowed into 128x128 pixel boxes. 
Images were normalized to the same mean and standard deviation and high-pass 
filtered at a low-resolution cut-off of ~200 Å. They were centered, and subjected to a 
first round of multi-statistical analysis (MSA).  An initial reference set was obtained 
using reference free classification in IMAGIC-4D (Image Science Software, GmbH). 
The best classes corresponding to characteristic side views of the C9 cylindrical 
particles were used as references for the multireference alignment (MRA). For CsgG:E 
complex, the first 3D model was calculated from the best 125 characteristic views 
(with good contrast and well defined features) encompassing 1221 particles of the 
complex with orientations determined by angular reconstitution (Image Science 
Software, GmbH). The 3D map was refined by iterative rounds of MRA, MSA and 
anchor set refinement. The resolution was estimated by Fourier Shell Correlation 
(FSC) accordingly to the 0.5 criteria level as 24 Å (Extended Data Fig. 7). 
Visualization of the map and figures were done in UCSF Chimera  50.  
 
Bile salt toxicity assay 
Outer membrane permeability was investigated by reduced growth on agar plates 
containing bile salts. Five l of tenfold serial dilutions of E. coli LSR12 7 cells 
harbouring both pLR42 16 and pMC2 14 (or derived Helix 2 mutants) were spotted on 
McConkey agar plates containing 100 g L-1 ampicillin, 25 g L-1 chloramphenicol, 1 
mM IPTG with or without 0.2% (w/v) L-arabinose. After overnight incubation at 37°C 
colony growth was examined.  
 
Single-channel current recordings 
Single-channel current recordings were performed using parallel high-resolution 
electrical recording with the Orbit 16 kit from Nanion (Munich, Germany). Briefly, 
horizontal bilayers of 1,2-diphytanoyl-sn-glycero-3-phosphocholine (Avanti Polar 
Lipids) were formed over microcavities (of sub-picoliter volume) in a 16-channel 
multielectrode cavity array (MECA) chip (Ionera, Freiburg, Germany) 51. Both the cis 
and trans cavities above and below the bilayer contained 1.0 M KCl, 25 mM Tris-HCl, 
pH 8.0. To insert channels into the membrane, CsgG dissolved in 25 mM Tris pH 8.0, 
500 mM NaCl, 1 mM DTT, 0.5% C8E4, 5 mM LDAO was added to the cis 
compartment to a final concentration of 90 – 300 nM. To test the interaction of the 
CsgG channel with CsgE, a solution of the latter protein dissolved in 25 mM Tris pH 
8.0 and 150 mM NaCl was added to the cis compartment to a final concentration of 
0.1, 1, 10 and 100 nM. Transmembrane currents were recorded at a holding potential 
of +50 mV and -50 mV (with the cis side grounded) using a Tecella Triton 16 channel 
amplifier at a low-pass filtering frequency of 3 kHz and a sampling frequency of 10 
kHz. Current traces were analyzed using the Clampfit of the pClamp suite (Molecular 
Devices, USA). Plots were generated using Origin 8.6 (Microcal, USA) 52.  
Measured currents were compared with those calculated based on the pore dimensions 
of the CsgG X-ray structure, modeled to be composed of three segments: (1) the 
transmembrane section, (2) the periplasmic vestibule, and (3) the inner channel 
constriction connecting the two. The corresponding resistances were calculated as: 
R1 =L1/( π D1d1 κ )  
R2 =L2 /( π D2d2 κ ) 
R3 =L3 /( π d1d2 κ ) 
where L1, L2, and L3 are the axial lengths of the segments, measuring 3.5 nm, 4.0 nm, 
and 2.0 nm, respectively, and D1, d1, D2 and d2 are the maximum and minimum 
diameters of segments 1 and 2, measuring 4.0 nm, 0.8 nm, 3.4 nm, and 0.8 nm, 
respectively. The conductivity κ has a value of 10.6 S m-1. The current was calculated 
by inserting R1, R2 and R3 and voltage V = 50 mV into: 
 I =V/(R1+R2 +R3)  
Access resistance was not found to significantly alter the predicted current. 
 
Extended Data: 
Extended Data Figure 1 | Curli biosynthesis pathway in E. coli. The major curli 
subunit CsgA (light green) is secreted from the cell as a soluble monomeric protein. 
The minor curli subunit CsgB (dark green) is associated with the outer membrane 
(OM) and acts as a nucleator for the conversion of CsgA from a soluble protein to 
amyloid deposit. CsgG (orange) assembles into an oligomeric curli-specific 
translocation channel in the OM. CsgE (purple) and CsgF (light blue) form soluble 
accessory proteins required for productive CsgA and CsgB transport and deposition. 
CsgC forms a putative oxido-reductase of unknown function. All curli proteins have 
putative Sec signal sequences for transport across the cytoplasmic (inner) membrane 
(IM). 
 
Extended Data Figure 2 | In solution oligomerization states of CsgG and CsgGC1S 
analyzed by size exclusion chromatography and negative-stain electron 
microscopy. (a) Raw negative-stain EM image of C8E4/LDAO-solubilized CsgG. 
Arrows indicate the different particle populations as labeled in the size exclusion 
profile shown in panel (g), being (a) aggregates of CsgG nonamers (b) CsgG 
octadecamers and (c) CsgG nonamers. Scale bar: 20 nm. (b) Representative class-
average for top- and side-views of the indicated oligomeric states. (c) Rotational auto-
correlation function graph of LDAO-solubilized CsgG in top view, showing 9-fold 
symmetry. (d) Raw negative-stain EM image of CsgGC1S. Arrows indicate the 
hexadecameric (d) and octameric (e) particles observed by size exclusion 
chromatography in panel (g). (e) Representative class-average for side-views of 
CsgGC1S oligomers. No top views were observed for this construct. (f) Table of elution 
volumes (EV) of CsgGC1S and CsgG particles observed by size exclusion 
chromatography shown in panel (g), calculated MW (MWcalc), expected MW 
(MWCsgG) according CsgG oligomerization state (CsgGn) and the particles symmetry 
as observed by negative-stain EM and X-ray crystallography. (g) Size exclusion 
chromatogram of CsgGC1S (black) and C8E4/LDAO-solubilized CsgG (grey) ran on 
Superdex 200 10/300 GL (GE Healthcare). (h, i) Ribbon representation of crystallized 
oligomers in top and side view show the D8 hexadecamers for CsgGC1S (h) and D9 
octadecamers for membrane-extracted CsgG (i). One protomer is colored in rainbow 
from N-terminus (blue) to C-terminus (red). The two C8 octamers (CsgGC1S) or C9 
nonamers (CsgG) that form the tail-to-tail dimers captured in the crystals are colored 
blue and tan. ‘r’ and ‘θ’ give radius and interprotomer rotation. 
 
Extended Data Figure 3 | Comparison of CsgG with structural homologues and 
interprotomer contacts in CsgG. (a) Ribbon diagram for the CsgGC1S monomer (eg. 
CsgG in pre-pore conformation) and (b) the nucleotide binding domain-like domain of 
TolB (PDB entry: 2hqs), respectively, colored both in rainbow from N-terminus (blue) 
to C-terminus (red). Common secondary structure elements are labeled equivalently. 
(c) Panels show CsgGC1S (grey) in superimposition with, from left to right, 
Xanthomonas campestris rare lipoprotein B (PDB entry: 2r76, colored pink), 
Shewanella oneidensis hypothetical lipoprotein – DUF330 (PDB entry: 2iqi, colored 
pink) and Escherichia coli TolB (PDB entry 2hqs, colored pink and yellow for the 
NTD and beta-propeller domain, resp.). CsgG-specific structural elements are labeled 
and colored as in upper left panel. (d, e) Ribbon diagram of two adjacent protomers as 
found in the CsgG structure, viewed along the plane of the bilayer, either from out-  
(c) or inside (d) the oligomer. One protomer is shown in rainbow (dark blue to red) 
from N- to C-terminus, a second protomer is shown in light blue (core domain), blue 
(helix 2 and tan (TM domain). Four main oligomerization interfaces are apparent: (1) 
6-3’ main chain interactions inside the -barrel, (2) the constriction loop (CL), (3) 
side chain packing of helix 1 (1) against 1-3-4-5 and (4) helix-helix packing of 
helix 2 (2). The 18-residue N-terminal loop connecting the lipid anchor (a magenta 
sphere shows C position of Leu 2) and N-terminal helix (N) is also seen to wrap 
over the adjacent two protomer. The projected position of the lipid anchor is expected 
to lie against the TM1 and TM2 hairpins of the +2 protomer  (not shown for clarity). 
 
 
Extended Data Figure 4 | Cys accessibility assays for selected surface residues in 
the CsgG oligomers. Ribbon representation of CsgG nonamers shown in periplasmic 
(a), side (b) or extracellular view (c). One protomer is colored in rainbow from N-
terminus (blue) to C-terminus (red). Cysteine substitutions are labeled and the 
equivalent locations of the S atoms are shown as spheres, colored according 
accessibility to maileimide-polyethyleneglycol (MAL-PEG, 5000 Da) labeling in E. 
coli outer membranes (d). Western blot of MAL-PEG reacted samples analyzed on 
SDS-PAGE show 5 kDa increase upon MAL-PEG binding of the introduced cysteine. 
Accessible (++ and +++), medium accessible (+) and inaccessible (-) sites are colored 
green, orange or red in the panels a, b, c and e. For R97 and R110 a second species at 
44 kDa is present, corresponding to a fraction of protein where both the introduced 
and native cysteine got labeled. (e) Side view of the dimerization interface in the D9 
octadecamer as present in the X-ray structure. Introduced cysteines in the dimerization 
interface or inside the lumen of the D9 particle are labeled. In membrane-bound CsgG, 
these residues are accessibility to MAL-PEG, demonstrating that the D9 particles are 
an artifact of concentrated solutions of membrane-extracted CsgG and that the C9 
complex forms the physiologically relevant species. Residues in the C-terminal helix 
(C; K242, D248 and H255) are found to be non- to poorly accessible, indicating C 




Extended Data Figure 5 | Molecular dynamics simulation of CsgG constriction 
with model poly-alanine chain. Top (a) and side (b) view of the CsgG constriction 
modeled with a poly-alanine chain threaded through the channel in an extended 
conformation, here shown in C- to N-terminal direction. Substrate passage through the 
CsgG transporter is itself non sequence-specific16,23. For clarity, a poly-alanine chain 
was used for modeling the putative interactions of a passing polypeptide chain. The 
modeled area is composed of 9 concentric CsgG C-loops, each comprising residues 47 
to 58. Side chains lining the constriction are shown in stick representation, with F51 
colored slate blue, N55 (amide-clamp) colored cyan, F48 and F56 (-clamp) in light 
and dark orange, resp. N, O and H atoms (only hydroxyl or side chain amide H’s are 
shown) are colored blue, red and white, resp. The poly-alanine chain is colored green, 
blue, red and white for C, N, O and H atoms respectively. Solvent molecules (water) 
within 10 Å from the poly-alanine residues inside the constriction (residues labeled +1 
to +5) are shown as red dots. Panel (c) shows modeled solvation of the poly-alanine 
chain, position as in panel (b) and with C-loops removed for clarity (shown solvent 
molecules are those within 10 Å of the full poly-alanine chain). The height of the 
amide- and -clamps, the solvation of the poly-alanine chain is reduced to a single 
water shell that bridges the peptide backbone and amide-clamp side chains. Most side 
chains in the Y51 ring have rotated towards the solvent as compared to their inward, 
center pointing position observed in the CsgG (as well as CsgGC1S) X-ray structure. 
The model is the result off a 40 ns all atom explicit solvent molecular dynamics 
simulation with GROMACS53  using the AMBER99SB-ILDN54 force field and with 




Extended Data Figure 6 | Sequence conservation in CsgG homologues. (a) Surface 
representation of the CsgG nonamer colored according to sequence similarity (colored 
yellow to blue from low to high conservation score)55 and viewed from the periplasm 
(far left), the side (middle left), the extracellular (middle right) or as a cross-sectional 
side view (far right). The figures show that the regions of highest sequence 
conservation map to the entry of the periplasmic vestibule, the vestibular side of the 
constriction loop and the luminal surface of the TM domain. (b) Multiple sequence 
alignment (MST) of CsgG-like lipoproteins. The selected sequences were chosen from 
monophyletic clades across the phylogenetic three of CsgG-like sequences (not 
shown) in order to give a representative view of sequence diversity. Secondary 
structure elements are shown as arrows or bars for -strands and -helices, 
respectively, and are based on the E. coli CsgG crystals structure. (c, d) CsgG 
protomer in secondary structure representation (c) and a cross-sectional side view (d) 
of the CsgG nonamer in surface representation, both colored grey and with three 
continuous blocks of high sequence conservation colored red (HCR1), blue (HCR2) 
and yellow (HCR3). HCR1 and HCR2 shape the vestibular side of the constriction 
loop, HCR3 corresponds to helix 2, lying at the entry of the periplasmic vestibule. 
Inside the constriction, F56 is 100% conserved, whilst N55 can be conservatively 
substituted by Ser or Thr, eg. by a small polar side chain that can act as H-bond donor 
/ acceptor. The concentric side chain ring at the exit of the constriction (Y51) is not 
conserved. Strikingly, the presence of the Phe-ring at the entrance of the constriction is 
topologically similar the Phe427-ring (referred to as -clamp) in the Anthrax protective 
antigen PA63, where it was shown to catalyzes polypeptide capture and passage
20. 
MST of toxB superfamily proteins reveals a conserved motif D(D/Q)F(S/N)S at the 
height of the Phe-ring. This is similar to the S(Q/N/T)FST motif seen in curli-like 
transporters. Although an atomic resolution structure of PA63 in pore conformation is 
not yet available, available structures suggest the Phe-ring may similarly be followed 
by a conserved H-bond donor / acceptor (S/N428) as a subsequent concentric ring in the 
translocation channel (note that the orientation of element is inversed in both 
transporters).   
 
 
Extended Data Figure 7 | CsgE oligomer and CsgG:CsgE complex. (a) Size 
exclusion chromatography of CsgE (Superose 6, 16/600; running buffer 20 mM Tris-
HCl pH8, 100 mM NaCl, 2.5% glycerol) shows an equilibrium of two oligomeric 
states, (1) and (2), with an apparent MW ratio of 9.16. Negative stain EM inspection 
of peak (1) shows discrete CsgE particles (5 representative class averages show inset, 
ordered by increasing tilt angles) compatible in size with 9 CsgE copies (b) Selected 
class average of CsgE oligomer observed in top view by cryo-EM and its rotational 
autocorrelation show the presence of C9 symmetry. (c) Fourier Shell Correlation (FSC) 
analysis of CsgG:CsgE cryo-EM model. 3D reconstruction achieved a resolution of 24 
Å as determined by Fourier shell correlation at a threshold of 0.5 correlation using 125 
classes corresponding to 1221 particles. (d) Overlay of CsgG:CsgE cryo-EM density 
and the CsgG nonamer observed in the X-ray structure. The overlays are shown 
viewed from the side as semi-transparent density (left) or as a cross-sectional view. (e) 
Congo Red binding of E. coli BW25141DcsgG complemented with wild type csgG 
(WT), empty vector (DcsgG) or csgG helix 2 mutants (single amino acid replacements 
labeled in single letter code). (f) Effect of bile salt toxicity on E. coli LSR12 
complemented with csgG (WT), or csgG carrying different helix 2 mutations, 
complemented with (+) or without (-) csgE. Tenfold serial dilution starting from 107 
bacteria were spotted on McConkey agar plates. Expression of the CsgG pore in the 
OM leads to an increased bile salt sensitivity that can be blocked by co-expression of 
CsgE . (g) Cross-sectional view of CsgG X-ray structure in molecular surface 
representation. CsgG mutants without an effect on CR binding or toxicity are shown in 
blue, mutants that interfere with CsgE-mediated rescue of bile salt sensitivity are 
indicated in red. 
 
 
Extended Data Figure 8 | Single-channel current analysis of CsgG and CsgG + 
CsgE pores. (a) Under negative field potential, CsgG pores show two conductance 
states. Upper left and right panels show a representative single-channel current trace 
of, respectively, the regular (measured at +50 mV, 0 mV and -50 mV) and low 
conductance forms (measured at 0 mV, + 50 mV, and - 50 mV. No conversions 
between both states were observed during the total observation time (n=22), indicating 
the conductance states have long life times (second to minute timescale). Lower left 
panel shows current histogram of regular and low conductance CsgG pores acquired at 
+ 50 mV and - 50 mV (n=32). IV curves for CsgG pores with regular and low 
conductance are shown in the lower right panel. The data represent the averages and 
standard deviations from at least 4 independent recordings. The nature or 
physiological existence of the low conductance form are unknown. (b) 
Electrophysiology of CsgG channels titrated with the accessory factor CsgE. The plots 
display the fraction of open, intermediate, and closed channel as a function of CsgE 
concentration. Open and closed states of CsgG are illustrated in Fig. 4f of the main 
manuscript. Increasing the concentration of CsgE to over 10 nM leads to the closure of 
CsgG pores. The effect occurs at both + 50 mV (left) and – 50 mV (right) ruling out 
the possibility that the pore blockade can be explained by electrophoresis of CsgE 
(calculated pI 4.7) into the CsgG pore. An infrequent (<5%) intermediate state has 
approximately half the conductance of the open channel. It may represent CsgE-
induced incomplete closures of the CsgG channel, or alternatively, it could represent 
the temporary formation of a CsgG dimer caused by the binding of residual CsgG 
monomer from the electrolyte solution to the membrane-embedded pore. The fraction 
for the three states was obtained from all-point histogram analysis of single-channel 
current traces. The histograms yielded peak areas for up to three states, and the 
fraction for a given state was obtained by dividing the corresponding peak area by the 
sum of all other states in the recording. Under negative field potential two open 
conductance states are discerned, similar to the observations for CsgG (see (a)). As 
both open channel variations were blocked by higher CsgE concentrations, the “open” 
traces in panel b combine both conductance forms. The data in the plot represent the 
averages and standard deviations from three independent recordings and channels. (c) 
The crystal structure, size exclusion chromatography and EM show that detergent 
extracted CsgG pores forms non-native tail-to-tail stacked dimers (eg. two 9-mers as 
D9 particle, Extended Data Fig. 2) at higher protein concentration. These dimers can 
also be observed in single channel recordings. Upper panel shows the single-channel 
current trace of a stacked CsgG pore at + 50 mV, 0 mV, and - 50 mV (left to right). 
Lower left panel shows current histogram of dimeric CsgG pores recorded at + 50 mV 
and - 50 mV. The experimental conductances of +16 ±2 and –16 ±3 pA (n=29) at + 
and – 50mV, respectively, are near the theoretically calculated value of 23 pA. Lower 
right panels shows IV curves for stacked CsgG pores. The data represent the averages 
and standard deviations from six independent recordings. (d) The possibility of CsgE 
to bind and block stacked CsgG pores was tested by electrophysiology. Single-channel 
current traces of stacked CsgG pore in the presence of 10 nM or 100 nM CsgE at + 50 
mV (upper), and – 50 mV (lower). The current traces show that otherwise saturating 
concentrations of CsgE do not lead to pore closure in case of stacked CsgG dimers. 
These observations are in good agreement with the mapping of the CsgG:CsgE contact 
zone to helix 2 and the mouth of the CsgG periplasmic cavity as discerned by EM and 
site-directed mutagenesis (Fig. 4 and Extended Data Fig. 7). 
 
 
Extended Data Figure 9 | Assembly and substrate recruitment of the CsgG 
secretion complex. The curli transporter CsgG and the soluble secretion co-factor 
CsgE form a secretion complex with 9:9 stoichiometry that encloses a ~24.000 Å3 
chamber that is proposed to entrap the CsgA substrate and facilitate its entropy-driven 
diffusion across the outer membrane (OM; Main text and Fig. 4). On theoretical 
grounds, three putative pathways for substrate recruitment and assembly of the 
secretion complex can be envisaged: (a) A catch-and-cap mechanism that entails the 
binding of CsgA to the apo CsgG translocation channel (1), leading to a 
conformational change in the latter that exposes a high affinity binding platform for 
CsgE binding (2). CsgE binding leads to capping of the substrate cage. Upon secretion 
of CsgA, CsgG would fall back into its low affinity conformation, leading to CsgE 
dissociation and liberation of the secretion channel for a new secretion cycle. (b) A 
dock-and-trap mechanism where periplasmic CsgA is first captured by CsgE (1), 
causing the latter to adopt a high affinity complex that docks onto the CsgG 
translocation pore (2), enclosing CsgA into the secretion complex. CsgA binding 
could be directly to CsgE oligomers or CsgE monomers, the latter leading to 
subsequent oligomerization and CsgG binding. Secretion of CsgA leads CsgE to fall 
back into its low affinity conformation and to dissociate from the secretion channel. 
(c) In a third model, CsgG and CsgE form a constitutive complex, where CsgE 
conformational dynamics cycle between an open and closed form in function of CsgA 
binding.  
Currently published or available data do not allow us to discriminate or put forward 
one of the putative recruitment modes or derivatives thereof.  
 
 
Extended Data Figure 10 | Data collection statistics and electron density maps of 
CsgGC1S and CsgG. (a) Data collection statistics for CsgGC1S and CsgG X-ray 
structures (b) 2.8 Å electron density map for CsgGC1S calculated using NCS-averaged 
and density-modified experimental SAD phases, and contoured at 1.5 . The map 
shows the region of the channel construction (CL; a single protomor is labeled) and is 
overlaid on top of the final refined model. (c) Electron density map (resolution: 3.6 Å, 
3.7 Å and 3.8 Å along reciprocal vectors a*, b* and c*, resp.) in the CsgG TM domain 
region, calculated from NCS-averaged and density modified molecular replacement 
phases (TM loops were absent from the input model), B-factor sharpened by -20 Å2 
and contoured at 1.0 . The shows the TM1 (K135-L154) and TM2 (L182-N209) 
region of a single CsgG protomer, overlaid on the final refined model. 
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